Hemispherx Biopharma (NYSE:HEB)

Hemispherx Biopharma (NYSE:HEB)


Share Price
$ 0.17
Change
-0.0048 (-2.74 %)
Market Cap
$8.33 m
Proactive Investors - Run By Investors For Investors

Hemispherx Biopharma

Hemispherx Biopharma is an advanced specialty biopharmaceutical company. It engages in the clinical development and manufacture of products to treat unserved and poorly served, serious medical conditions including Chronic Fatigue Syndrome (CFS), refractory HPV genital warts, refractory HCV and MS,  seasonal and pandemic flu, as well as immune enhancers to be used with preventative and...

EPIC: HEB
Market: NYSE:HEB
52-week High/Low: $0.34 / $0.15
Sector: Pharmaceuticals
Market Cap: $8.33 m
Website: www.hemispherx.net
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Hemispherx Biopharma


Hemispherx Biopharma Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use